Protalix BioTherapeutics, Inc. (PLX) Ownership

$2.43

north_east
$0.09 (3.85%)
Day's range
$2.33
Day's range
$2.52

Protalix BioTherapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 3.55 M $7.88 M   5.38% 4.51%
OPALEYE MANAGEMENT INC. 11/14/2025 2.58 M $5.73 M   100.00% 3.28%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 1.32 M $2.92 M   -18.55% 1.67%
NORTHERN TRUST CORP 11/14/2025 902.46 K $2.00 M   -16.42% 1.15%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 819.78 K $1.82 M   -0.79% 1.04%
STRATOS WEALTH PARTNERS, LTD. 11/06/2025 500.00 K $1.11 M   42.86% 0.64%
STATE STREET CORP 11/14/2025 498.55 K $1.11 M   12.23% 0.63%
VANGUARD GROUP INC 11/07/2025 464.42 K $1.03 M   -4.20% 0.59%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 11/13/2025 400.40 K $888.88 K   -19.31% 0.51%
UBS GROUP AG 11/13/2025 190.28 K $422.41 K   153.19% 0.24%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 189.10 K $419.80 K   0.00% 0.24%
DIAMETRIC CAPITAL, LP 11/13/2025 179.98 K $399.56 K   25.62% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 175.07 K $388.66 K   0.00% 0.22%
COMMONWEALTH EQUITY SERVICES, LLC 10/22/2025 171.77 K $381.00 K   -12.72% 0.22%
EVERGREEN CAPITAL MANAGEMENT LLC 10/28/2025 171.34 K $380.37 K   0.00% 0.22%
GOLDMAN SACHS GROUP INC 11/14/2025 150.83 K $334.84 K   47.61% 0.19%
BANK OF NEW YORK MELLON CORP 11/03/2025 138.55 K $307.58 K   3.17% 0.18%
MAIN STREET FINANCIAL SOLUTIONS, LLC 11/14/2025 129.10 K $286.60 K   100.00% 0.16%
BARCLAYS PLC 11/12/2025 101.80 K $225.99 K   -19.82% 0.13%
NUVEEN, LLC 11/12/2025 90.19 K $200.22 K   0.00% 0.11%
XTX TOPCO LTD 11/14/2025 85.84 K $190.57 K   16.51% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 72.92 K $161.89 K   -75.58% 0.09%
MORGAN STANLEY 11/14/2025 71.04 K $157.70 K   -84.63% 0.09%
WOLVERINE TRADING, LLC 11/14/2025 70.39 K $152.05 K   187.23% 0.09%
DEUTSCHE BANK AG\ 11/13/2025 65.62 K $145.67 K   100.00% 0.08%
RHUMBLINE ADVISERS 11/06/2025 65.19 K $144.72 K   -6.59% 0.08%
ORIN GREEN FINANCIAL, LLC 10/28/2025 61.20 K $135.86 K   0.00% 0.08%
PRELUDE CAPITAL MANAGEMENT, LLC 11/14/2025 49.79 K $110.54 K   -11.17% 0.06%
INVESCO LTD. 11/13/2025 45.00 K $99.91 K   -0.31% 0.06%
WELLS FARGO & COMPANY/MN 11/13/2025 42.83 K $95.09 K   18.86% 0.05%
NEW YORK STATE COMMON RETIREMENT FUND 11/03/2025 41.30 K $91.69 K   -40.14% 0.05%
STATE OF WYOMING 11/04/2025 39.02 K $86.62 K   100.00% 0.05%
CITADEL ADVISORS LLC 11/14/2025 37.31 K $82.82 K   100.00% 0.05%
JANE STREET GROUP, LLC 11/14/2025 36.50 K $81.03 K   100.00% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 35.28 K $79.00 K   0.00% 0.04%
WOLVERINE TRADING, LLC 11/14/2025 32.80 K $70.85 K   57.69% 0.04%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2025 32.25 K $71.60 K   -15.29% 0.04%
INTECH INVESTMENT MANAGEMENT LLC 11/12/2025 31.25 K $69.37 K   -14.37% 0.04%
JPMORGAN CHASE & CO 11/26/2025 29.99 K $66.58 K   -13.18% 0.04%
CAPITAL PERFORMANCE ADVISORS LLP 10/22/2025 25.98 K $57.67 K   0.00% 0.03%
APTUS CAPITAL ADVISORS, LLC 11/12/2025 25.73 K $57.11 K   3.52% 0.03%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/14/2025 24.05 K $53.40 K   100.00% 0.03%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 23.60 K $52.39 K   -85.94% 0.03%
BANK OF AMERICA CORP /DE/ 11/14/2025 20.12 K $44.66 K   -8.10% 0.03%
POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 11/12/2025 18.55 K $41.19 K   0.00% 0.02%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 17.03 K $37.53 K   -62.63% 0.02%
CASCADE FINANCIAL PARTNERS, LLC 10/21/2025 17.00 K $37.74 K   0.00% 0.02%
VIRTU FINANCIAL LLC 11/14/2025 16.53 K $37.00 K   100.00% 0.02%
CITADEL ADVISORS LLC 11/14/2025 15.80 K $35.08 K   49.06% 0.02%
LIDO ADVISORS, LLC 11/14/2025 15.55 K $34.53 K   0.00% 0.02%

Protalix BioTherapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 85 institutional investors and hedge funds held shares of Protalix BioTherapeutics, Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 3.55 M

Opaleye Management Inc.: 2.58 M

RENAISSANCE TECHNOLOGIES LLC: 1.32 M

NORTHERN TRUST CORP: 902,459

GEODE CAPITAL MANAGEMENT, LLC: 819,777

Stratos Wealth Partners, LTD.: 500,000

17.69% of Protalix BioTherapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 14.27 M shares in the last 24 months. This purchase volume represents approximately $34.67 M in transactions.